chrisvoncsefalvay/vaers-outcomes huggingface dataset:
2 patients got COVID19 10 days following vaccination; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (2 patients got COVID19 10 days following vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (2 patients got COVID19 10 days following vaccination). At the time of the report, COVID-19 (2 patients got COVID19 10 days following vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported
Pt was given  a more concentrated dose of Pfizer vaccine. Nurse mixed 0.8 ml of  sterile saline instead of 1.8 ml. Nurse did not double check with another nurse the mixture/dose of medication prior to giving to patient.
Nausea, chills, headache about an hour after receiving vaccine. *Patient has had Typhoid vaccine in the past without reaction (2006).
Pain started on the upper thigh in left leg, caused staying in bed for three days. Tried to stretch out the legs, but had pain every time. ON 4/11/21 had difficulty breathing, so called 911 and was taken to the ER. Diagnosed with pulmonary embolism/
Patient with two Moderna COVID vaccinations, last dose 02/12/21, who admitted to hospital with GI distress who tested detected for COVID upon admission.  Provider discharge note below:  "patient presented with n/v/abdominal pain/diarrhea as well as low back pain found to have covid, hyponatremia, AKI and pyuria. Started on rocephin, fluids with slow improvement of kidney function and improvement of flank/back pain. GI symptoms resolved. Sodium stayed low, testing supported poor solute intake, this improved with salt tablets. Unclear if truly had UTI but was treated for such x5 days total (in and outpatient). Bmp in a week. No respiratory issues from covid."
Received vaccines on 3/29/12. Presented to ER on 4/1/12 with cellulitis at site where vaccines were given.
Pt recv vax in 12/97; 1-2 days post vax pt exp swollen vax site, fever (104F) w/ shaking chills
Fever, muscle aches and stabbing pains in arms, no appetite, headache, extreme fatigue, vertigo, chills, and nausea.  All symptoms left when fever broke at 9 PM the next day so vertually 24-hours and it was fine.  Fourteen days later, extreme fatigue hit me, pain in the arm when I got the shot, and random stabbing/nerve pain that I still have today.  I also have nausea.
Slightly less than a week after receiving the vaccine, large red raised and slightly itchy blotches appeared on my left arm just below the injection site. No treatment was needed, they appear to be slowly going away, but my PCP told me to report it
I want to say 13 hours after receiving my vaccine I felt slightly feverish and i felt like i was a little nauseated. For a few days after those symptoms went away but a few weeks later my blood pressure went from 192/122. All of a sudden i can see my blood pumping through my eyes. I could literally feel my blood pressure continuing to rise. I immediately took losartan to lower my blood pressure and started to do calming remedies to lower my blood pressure. After that it went down to a reasonable level but it was still a little high.  After the first shot my prescription was raised 50 mg 1 x day, but my second dose it spiked to an all time high and i ended up taking 50mg in the morning and in the afternoon.
Severe pain in left arm where the injection was given.  Pain began about an hour after injection and increased in severity.  Pain was so severe the first night that it interrupted sleep.  The following day the pain made it difficult to drive, conduct normal activities.  The only way to use arm was to physically lift it with the other arm, which caused enormous pain.  Pain gradually began subsiding about 48 hours after injection.
Varicella date; given on 6/22/12. Date = 7/3/12 vesicles/varicella-like lesions appeared.
Rash/skin irritation continuing 2 months after getting the vaccine; Rash/skin irritation continuing 2 months after getting the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SKIN IRRITATION (Rash/skin irritation continuing 2 months after getting the vaccine) and RASH (Rash/skin irritation continuing 2 months after getting the vaccine) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Allergic to dogs, cats, dust mites, cockroaches.  Concurrent medical conditions included Allergic to dogs, Allergic to cats, Dust allergy and Cockroach allergy.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 27-Apr-2021, the patient experienced SKIN IRRITATION (Rash/skin irritation continuing 2 months after getting the vaccine) and RASH (Rash/skin irritation continuing 2 months after getting the vaccine). On 27-Jun-2021, RASH (Rash/skin irritation continuing 2 months after getting the vaccine) had not resolved. At the time of the report, SKIN IRRITATION (Rash/skin irritation continuing 2 months after getting the vaccine) had not resolved.            No concomitant product use was provided by the reporter. No treatment medication was provided.
Pt developed dizziness, palpitations, and fatigue.  One episode of syncope while running.  Continues to have evidence of dizziness and palpitationss at least every week.  chest heaviness on daily basis.
No wheal formed on the 1st attempt; 2nd dose given and wheal formed on 2nd attempt
About 11-12 hrs after receiving the second covid vaccine, I woke up in the middle of the night with a bad headache and extremely nauseous. I did not experience a fever or body aches. For the next 24 hrs I had nausea and vomiting on and off. Eventually it was accompanied with chills. I haven?t spoke with anyone else yet that vomited from the vaccine, so I wanted to make sure I reported this.  By early afternoon 1/22 I felt back to normal.
Patient felt fine but stressed prior to vaccination of shot. Family going through medical trouble and talking about house burning down during vaccine (anxiety trigger in her past). Other than stress, patient was ok. Gave patient Boostrix. Administration went according to protocol. Asked patient to sit for 15 minutes and she started reporting dizziness and hand tremor. Asked patient to lay down and she refused. Asked if mouth felt tingling or swelling and it did not at first. I suggested she take one of her anxiety alprazolam to relax. Patient started getting more stressed as we talked and then reported her lips started to feel tingly. She reported half of her tongue does go numb when she smells certain smells. I stated that we do have many different scents in our store as we are a gift store. I asked if she would like me to call 911 as her mouth was starting to tingle and I stated I would prefer her have a reaction in the ER (1 block away) than in our store so she could get proper medical treatment. She refused. I asked if I could get her husband here and went out to their truck and informed husband of the situation. He came in and drove her to the ER. Prior to them leaving, I contacted the local ER and gave them a rundown of the events leading up to their admission. Followed up with clinic every hour times 2 when patient was sent home. She received benadryl IV and relaxed. Dr did not report anaphylaxis.
Mother reports pt developed wheezing on the same day as administration of Prevnar with DTAP, HIB and HBV on 12/13/00. Same symptoms occurred on 3/30/01 after receiving Prevnar and IPV. On 4/1/01 pt was seen by doctor and dx'd with bronchiolitis and otitis.
Order was given for PEDIARIX and HIB; PENTACEL and HIB were administered inadvertently.
This spontaneous case reported by a non-healthcare professional, describes the occurrence of pain in extremity (arm), asthenia (felt very weak), dizziness (lightheaded) and nausea in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. Previous vaccinations included Pfizer dose 1 and 2. No adverse event occurred with either vaccine. On Jan 4, 2022, patient received the third dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 5, 2022, patient experienced  pain in extremity (arm), asthenia (felt very weak), dizziness (lightheaded) and nausea. At the time of the report, pain in extremity (arm), asthenia (felt very weak), dizziness (lightheaded) and nausea outcome: unknown. Diagnostic results: On Jan 5, 2021 blood pressure measurement/blood pressure changes: result not reported (inconclusive). No concomitant medication or treatment information provided. Reporter did not allow further contact.
severe diarrhea; bedridden 3-4 days; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Amoxicillin).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days). At the time of the report, DIARRHOEA (severe diarrhea) and BEDRIDDEN (bedridden 3-4 days) outcome was unknown. Not Related      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Itchy, red rash on abdomen and back. Injection site red, swollen and feverish.
At 9:00 PM on 9/7/13. Pt. noticed itching at neck - noted bumps at neck with quarter sized red area. Few bumps at neck with quarter sized red  area. Few bumps noted down to chest and back area (very few) - still itching. Has stayed the same through today. Oral benadryl has not helped . Topical benadryl has helped. No new jewelry or lotions at neck area.
tested positive for Covid-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a health care professional and describes the occurrence of COVID-19 (tested positive for Covid-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced COVID-19 (tested positive). At the time of the report, COVID-19 (tested positive for Covid-19) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Jan-2021, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   They had to wait 90 days after monoclonal antibodies infusion before patient can receive the 2nd dose which they are scheduling on 13Apr2021.
Friday, Dec.10th 2021 16:32   During a Vaccination clinic, Medical Teams staff/volunteers administered a 1st dose of Pfizer covid vaccine to a 25-year-old female. Approx. 5 minutes later a volunteer flagged me down and reported that the patient was having difficulty breathing. I immediately stopped the clinic. Upon seeing the patient, she was obviously in respiratory distress. I instructed volunteer to activate 911. I then drew up 0.3 mg of epinephrine and RN administered to patient via IM (1635). Patient was then placed supine on the ground and her legs were elevated. Post epi administration, patient vitals: pulse 120, BP, 120/100, resp rate 20. Patient reported that beathing became easier post epi administration, but pain on inspiration. After four minutes patient reported her tongue and lips were feeling numb. We had drawn up a second 0.3 ml of Epi, but fire had arrived on scene(1644). Report was given to paramedics, and patient was handed off and transported by paramedics.
Child did not complain of itching nor rash noted. All vital signs: BP, Heart Rate, Temperature, and Breathing were in normal range
Pt developed local erythema, swelling, induration at injection site within one minute of VARIVAX injection - given po BENADRYL with decrease in local swelling & induration - few local urticarial rash present also.
inflammation of heart muscle, chest pain. Happened second day after vaccination. Symptoms resolved seventh day after vaccination.
This spontaneous report was received from a physician via company representatives and from a support services director concerning to a patient of unknown age and gender. Information about the patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications was not reported. On 20-JAN-2015, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 which had the lot # K009874 with expiration date 19-MAR-2016 (dosage number and route of administration were not reported). On unspecified dates, the vaccine had two temperature excursions; one for 336 hours in which the highest recorded temperature was 59 degrees Fahrenheit (15 degrees Celsius) and another one for 108 hours in which the lowest recorded temperature was -3 degrees Celsius. The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse effects were reported and no product quality complaint was involved. This is one of the several reports received from the same reporter. Additional information has been requested.
FEVER, MALAISE, CHILLS, LACK OF APPETITE, ABOUT 48 HOURS
chills  headaches tired, sore throat, coughing  still periodic coughing 2/4/2022
daughter who is under 18 received the vaccine; A spontaneous report received from a Consumer concerning, 17-year-old, female patient who received dose of Moderna COVID-19 vaccine.    The patient's medical history was not included. Patient's concomitant was not included.   On 19JAN2021, the patient received their 1st dose of the two planned doses of mRNA-1273 in unknown arm (Batch #: 025L20A) intramuscularly for prophylaxis of COVID-19 infection.   Patient father stated that his daughter who was under 18 received her 1st dost of the Moderna COVID-19 vaccine. Father stated when he took her back for the 2nd dose of the Moderna COVID-19 vaccine the facility denied her.   Treatment information was not included/ unknown.   Action taken with mRNA-1273 in response to the event was not provided.  The outcome of the event was considered as recovered.; Reporter's Comments: This report refers to a case of product administered to patient of inappropriate age (17 year old) for mRNA-1273 (lot number 025L20A) with no associated AEs reported.
"Pfizer-BioNT Covid-19Vaccine EUA" Because I am allergic to Hornet sings I waited 30 mins after the injection.  I was fine so I walked out to my truck.  I became flushed in the face and my mouth had a metallic taste so I walked back into the clinic to tell them.  They took my Blood pressure which was 200/125.  I felt very off so they wheeled me into Urgent Care where they gave me one benadryl and monitored my blood pressure.  They then called for ambulance for ER . I was released when my blood pressure was lower.  I will not get the second injection of Pfizer!
pt exp pains referable to shoulders & upper arms also quadriparesis; devel some type infectious disease process; malaise, elevated temp, infected tooth; lack of energy, aches & pains in muscles; hypalgesia & paresthesiae; progressive weakne
About 2 hours after receiving the flu vaccine- left arm at injection site became redness about the size of a silver dollar, feverish and swollen.  Immediately took Benadryl 25 mg, also had taken Tylenol 500mg prior to vaccine.   7 hours later at bedtime (10:30pm)- beginning to have redness radiate down the arm and redness at injection site was the size of an orange; repeated Benadryl 25mg.  Next morning, redness at injection site was size of a grapefruit and repeated Benadryl and additional Tylenol.  Afternoon, repeated Tylenol - injection site was about the same, applied ice pack. In PM, repeated Benadryl and tylenol.  On next day (Sunday) injection site redness had decreased to the size of an orange, and benadryl and tylenol were repeated.  Sunday pm- repeated Benadryl and tylenol.  Monday am- took tylenol - color of injection site fading, was pink not red. Monday pm- repeated benadryl and tylenol. Tuesday am- redness had dissipated completely, no swelling present.
Administered an expired vaccine. There was a different BUD and and expiration date which was that of 9/10/22. Instructions were not clear on what date to use therefore , instructed  to go by the expiration date  9/10 instead of BUD of 7/13.  Vaccine was administered by attending RN.
Pt. had a bump at injection site that was growing over time slowly. Pt. lost vision and hearing. Pt. began to faint. Adrenaline generic was administered. Pt. hearing and vision came back. Pt. bump on injection site went down.
got sicker than ever before; Initial information was received on 20-Nov-2020 regarding an unsolicited valid non-serious social media case.  This case involves patient (unknown demography) who got sicker than ever before (illness), while the patient received INFLUENZA VACCINE.  Medical history, medical treatment(s), concomitant medications, vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious got sicker than ever before (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  At the time of report, the outcome was unknown for the event.  There will be no information available on the batch number for this case.
Had problems with throat getting stuck/Heimlich to get food out; Sweating; Would drink water and have problems getting it down throat/Heimlich to get food out; Had problems breathing; can't think straight; Fever; Chills; Muscle soreness in back/Muscle soreness in legs; Muscle soreness in ankle; This spontaneous case was reported by a consumer and describes the occurrence of CHOKING (Had problems with throat getting stuck/Heimlich to get food out) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037b21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Cancer.    On 22-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Apr-2021, the patient experienced HYPERHIDROSIS (Sweating), DYSPHAGIA (Would drink water and have problems getting it down throat/Heimlich to get food out), DYSPNOEA (Had problems breathing), THINKING ABNORMAL (can't think straight), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle soreness in back/Muscle soreness in legs) and ARTHRALGIA (Muscle soreness in ankle). On an unknown date, the patient experienced CHOKING (Had problems with throat getting stuck/Heimlich to get food out) (seriousness criterion medically significant). At the time of the report, CHOKING (Had problems with throat getting stuck/Heimlich to get food out), HYPERHIDROSIS (Sweating), DYSPHAGIA (Would drink water and have problems getting it down throat/Heimlich to get food out), DYSPNOEA (Had problems breathing), THINKING ABNORMAL (can't think straight), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Muscle soreness in back/Muscle soreness in legs) and ARTHRALGIA (Muscle soreness in ankle) outcome was unknown.            Concominant medications included unknown cancer medications.  On an unknown date, treatment included the Heimlich maneuver.  The patient received both scheduled doses of mRNA-1273 prior to the events, therefore action taken with the drug in response to the events was not applicable.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
(I am not positive of the name of influenza vaccine, as his records just state "influenza quadrivent preservative free"). At 9:30am on 10/12/17, patient had a bowel movement that was full of visible blood- both large globs of red mucus as well as black strings appearing to be old blood. I called his pediatrician and asked if I could bring the diaper in for hemoccult blood testing because I suspected it to be blood and that he was having a vaccine reaction. They insisted it was impossible for him to be reacting to the eggs in the flu vaccine even if he has an FPIES allergy to eggs, but finally agreed to test the diaper. It tested positive for blood at both sites they tested (one from the red mucus area, one from the black strings). Following this diaper, he had another BM around 4pm with visible blood and a third around 6pm, also with visible blood. He was extremely irritable, and crying without being able to be consoled for most of the evening, and refused to eat dinner. He also refused to sleep in his crib, andI had to sleep with him right next to me in my bed where he slept very restlessly all night.
COVID-19  Fever, unspecified fever cause  Nasal congestion  Fatigue, unspecified type  Generalized body aches  Influenza B
Incorrect product administered; A spontaneous report was received from a Moderna employee concerning a patient who received Regeneron's COVID-19 monoclonal antibody treatment instead of Moderna's COVID-19 vaccine (mRNA-1273) and experienced the event, product administration error.   The patient's medical history was not provided. No relevant concomitant medications were reported.   On 30 Dec 2020, the patient received Regeneron's COVID-19 monoclonal antibody treatment intramuscularly instead of Moderna's COVID-19 vaccine (mRNA-1273).  No treatment information was provided.   There was no change planned to the dosing schedule of mRNA-1273 in response to the event. The patient would receive priority access to the first dose of mRNA-1273.   The event, product administration error, was considered resolved on 30 Dec 2020.; Reporter's Comments: This report refers to a case of Product administration error (incorrect product administered) for mRNA-1273, lot # unknown. There were no reported AEs associated with this case of Product administration error (incorrect product administered).
pt recv vax 1NOV98 & same day pt exp eye burning & itching, h/a & arm pain;pt sought unspecified medical attention;